We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Evaluates treatment effects in relapsed or refractory myeloma, suggesting potential improvement in outcomes.
No takes yet. Share an insight, caveat, or question.
Mina et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: